» Articles » PMID: 29038287

Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases

Overview
Specialty Nephrology
Date 2017 Oct 18
PMID 29038287
Citations 142
Authors
Affiliations
Soon will be listed here.
Abstract

Data indicate significant phenotypic and genotypic overlap, plus a common pathogenesis, between two groups of inherited disorders, autosomal dominant polycystic kidney diseases (ADPKD), a significant cause of ESRD, and autosomal dominant polycystic liver diseases (ADPLD), which result in significant PLD with minimal PKD. Eight genes have been associated with ADPKD ( and ), ADPLD (, , , , and ), or both (). Although genetics is only infrequently used for diagnosing these diseases and prognosing the associated outcomes, its value is beginning to be appreciated, and the genomics revolution promises more reliable and less expensive molecular diagnostic tools for these diseases. We therefore propose categorization of patients with a phenotypic and genotypic descriptor that will clarify etiology, provide prognostic information, and better describe atypical cases. In genetically defined cases, the designation would include the disease and gene names, with allelic (truncating/nontruncating) information included for Recent data have shown that biallelic disease including at least one weak ADPKD allele is a significant cause of symptomatic, very early onset ADPKD. Including a genic (and allelic) descriptor with the disease name will provide outcome clues, guide treatment, and aid prevalence estimates.

Citing Articles

Advances and Challenges in Modeling Autosomal Dominant Polycystic Kidney Disease: A Focus on Kidney Organoids.

Gu J, Liu F, Li L, Mao J Biomedicines. 2025; 13(2).

PMID: 40002937 PMC: 11852630. DOI: 10.3390/biomedicines13020523.


Implementation of a Kidney Genetic Service Into the Diagnostic Pathway for Patients With Chronic Kidney Disease in Canada.

Schott C, Arnaldi M, Baker C, Wang J, McIntyre A, Colaiacovo S Kidney Int Rep. 2025; 10(2):574-590.

PMID: 39990878 PMC: 11843117. DOI: 10.1016/j.ekir.2024.11.004.


Genetic analysis of autosomal dominant polycystic kidney disease in Iranian families: a combined Sanger and next-generation sequencing study.

Rafiee M, Razipour M, Keramatipour M, Roozbeh J, Entezam M J Appl Genet. 2025; .

PMID: 39951171 DOI: 10.1007/s13353-024-00937-1.


The need for clinical, genetic and radiological characterization of atypical polycystic kidney disease.

Righini M, Corsi C, Sciascia N, Aiello V, Ciurli F, Lerario S J Nephrol. 2025; .

PMID: 39928271 DOI: 10.1007/s40620-024-02181-6.


An extracellular vesicle based hypothesis for the genesis of the polycystic kidney diseases.

Hogan M, Ward C Extracell Vesicle. 2025; 4.

PMID: 39886526 PMC: 11781568. DOI: 10.1016/j.vesic.2024.100048.


References
1.
Drenth J, Te Morsche R, Smink R, Bonifacino J, Jansen J . Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet. 2003; 33(3):345-7. DOI: 10.1038/ng1104. View

2.
Prattichizzo C, Macca M, Novelli V, Giorgio G, Barra A, Franco B . Mutational spectrum of the oral-facial-digital type I syndrome: a study on a large collection of patients. Hum Mutat. 2008; 29(10):1237-46. DOI: 10.1002/humu.20792. View

3.
Cornec-Le Gall E, Audrezet M, Le Meur Y, Chen J, Ferec C . Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on. Hum Mutat. 2014; 35(12):1393-406. DOI: 10.1002/humu.22708. View

4.
Fedeles S, Gallagher A, Somlo S . Polycystin-1: a master regulator of intersecting cystic pathways. Trends Mol Med. 2014; 20(5):251-60. PMC: 4008641. DOI: 10.1016/j.molmed.2014.01.004. View

5.
DALGAARD O . Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl. 1957; 328:1-255. View